Matthew Nankivell

3PUBLICATIONS
42CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 29, 2025
Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/- Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability-High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data Pooled Analysis.

Alessandra Raimondi, Gabriele Tinè, Alexej Ballhausen

|Jul 19, 2023
Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma.

Matthieu Faron, Maurice Cheugoua-Zanetsie, Jayne Tierney

|Feb 18, 2022
Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.

Arnaldo N S Silva, Yuichi Saito, Takaki Yoshikawa

Pageof 1

Frequent Collaborators

3 joint publications

David Cunningham

2 joint publications

Guillaume Piessen

1 joint publications

Arnaldo N S Silva

1 joint publications

Yuichi Saito